Cyclin Dependent Kinases: Structural Biology Services

Cyclin-dependent kinases (CDKs) and their cyclin regulatory subunits form complexes that are essential for driving abnormal growth processes in cancer cells, making these proteins important targets for cancer treatment.

To support the discovery of novel CDK inhibitors, the WuXi AppTec Discovery Biology Structural Biology platform provides a wide range of biophysical, X-ray crystallography, and cryo-EM services for a variety of CDK family members, including CDK4, CDK6 and CDK7.

With decades of experience in structural biology and state-of-the-art infrastructure in Munich (Germany) and Suzhou (China), we are the ideal partner for your drug discovery program.

Cyclin Dependent Kinases_Structural Biology Services

Download